Guam joins multi-billion-dollar settlement talks in opioid cases

October 26, 2019, Tamuning, Guam- Attorney General (AG) Leevin Taitano Camacho joined in on the recent settlement discussions in the multi-state Purdue Pharmaceutical case involving OxyContin, the company’s blockbuster opioid drug. The award is valued at upwards of $3 billion, of which Guam will receive a portion. The award is expected to increase after the liquidation of Purdue’s assets.

The Office of the Attorney General (OAG) is also involved in a separate settlement discussion about opioid drugs produced by other pharmaceutical companies. A $48 billion settlement discussion is ongoing against drug manufacturers and distributors.

AG Camacho said, “It’s important for Guam to be part of the settlement conversations, securing every dollar we can to support the Island’s fight against our drug problem.”

In August, the OAG sued Purdue Pharma for designing, financing, and waging an aggressive marketing campaign to mislead prescribers, patients, and the public into believing their opioid drugs were safe to treat pain on a long-term basis.

“As a community, we have to take a multi-prong approach to combating our drug problem. Any settlement funds we receive should be committed to rehabilitation programs and other evidence-based programs that prevent drug abuse and address addiction,” added AG Camacho.

Deputy Attorney General Fred Nishihira, Assistant Attorneys General Janice Camacho, Joseph Perez, and Marinna Julian from the Consumer Protection Division are handling the cases. Settlement discussions will continue over the upcoming weeks.